AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
+0.0020 (100.00%)
Jan 22, 2025, 2:45 PM EST
AXIM Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 0.01 | 0.16 | 0.05 | 0.45 | 0.46 | 0.51 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 0.21 | Upgrade
|
Cash & Short-Term Investments | 0.01 | 0.16 | 0.05 | 0.45 | 0.46 | 0.73 | Upgrade
|
Cash Growth | -93.80% | 230.90% | -89.56% | -0.92% | -36.97% | -62.91% | Upgrade
|
Inventory | 0.01 | - | - | - | - | - | Upgrade
|
Prepaid Expenses | - | - | 0.04 | 0.16 | 0.26 | 0.08 | Upgrade
|
Other Current Assets | - | - | 0.01 | 0.02 | - | 0.84 | Upgrade
|
Total Current Assets | 0.02 | 0.16 | 0.1 | 0.64 | 0.71 | 1.64 | Upgrade
|
Property, Plant & Equipment | 0.3 | 0.36 | 0.11 | 0.19 | 0.23 | 0 | Upgrade
|
Goodwill | - | - | - | - | 2.46 | - | Upgrade
|
Other Intangible Assets | 3.4 | 3.59 | 3.99 | 4.38 | - | - | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | 7.8 | - | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | Upgrade
|
Total Assets | 3.73 | 4.12 | 4.21 | 5.32 | 11.31 | 1.69 | Upgrade
|
Accounts Payable | 1.67 | 2.78 | 1.32 | 0.85 | 0.76 | 0.75 | Upgrade
|
Accrued Expenses | - | - | - | 0.06 | 0.31 | - | Upgrade
|
Short-Term Debt | - | - | 0.03 | 1.61 | 0.37 | 0.04 | Upgrade
|
Current Portion of Leases | 0.09 | 0.09 | 0.02 | 0.06 | 0.05 | - | Upgrade
|
Current Unearned Revenue | 0.23 | 0.3 | 0.33 | - | - | - | Upgrade
|
Other Current Liabilities | 4.57 | 2.8 | 1.7 | 0 | 0 | 2.6 | Upgrade
|
Total Current Liabilities | 6.57 | 5.98 | 3.39 | 2.58 | 1.5 | 3.4 | Upgrade
|
Long-Term Debt | 6.6 | 5.66 | 5.64 | 5.06 | 5.84 | 5.06 | Upgrade
|
Long-Term Leases | 0.09 | 0.14 | - | 0.02 | 0.08 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 2.34 | - | Upgrade
|
Total Liabilities | 13.26 | 11.78 | 9.04 | 7.66 | 9.75 | 8.45 | Upgrade
|
Common Stock | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 65.18 | 64.53 | 59.19 | 51 | 43.2 | 28.62 | Upgrade
|
Retained Earnings | -74.75 | -72.18 | -64.13 | -57.88 | -41.85 | -35.44 | Upgrade
|
Comprehensive Income & Other | -0 | -0.02 | 0.09 | 4.53 | 0.2 | 0.05 | Upgrade
|
Total Common Equity | -9.53 | -7.66 | -4.83 | -2.34 | 1.57 | -6.76 | Upgrade
|
Shareholders' Equity | -9.53 | -7.66 | -4.83 | -2.34 | 1.57 | -6.76 | Upgrade
|
Total Liabilities & Equity | 3.73 | 4.12 | 4.21 | 5.32 | 11.31 | 1.69 | Upgrade
|
Total Debt | 6.78 | 5.89 | 5.69 | 6.75 | 6.34 | 5.1 | Upgrade
|
Net Cash (Debt) | -6.78 | -5.74 | -5.64 | -6.3 | -5.88 | -4.37 | Upgrade
|
Net Cash Per Share | -0.03 | -0.03 | -0.03 | -0.05 | -0.05 | -0.07 | Upgrade
|
Filing Date Shares Outstanding | 301.96 | 278.43 | 223.65 | 152 | 128.86 | 128.44 | Upgrade
|
Total Common Shares Outstanding | 294.46 | 245.93 | 192.44 | 138.1 | 125.33 | 64.85 | Upgrade
|
Working Capital | -6.55 | -5.82 | -3.29 | -1.94 | -0.78 | -1.76 | Upgrade
|
Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.02 | 0.01 | -0.10 | Upgrade
|
Tangible Book Value | -12.93 | -11.25 | -8.81 | -6.72 | -0.89 | -6.76 | Upgrade
|
Tangible Book Value Per Share | -0.04 | -0.05 | -0.05 | -0.05 | -0.01 | -0.10 | Upgrade
|
Machinery | 0.26 | 0.26 | 0.18 | 0.18 | 0.13 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.